Calcineurin inhibition normalizes β-adrenergic responsiveness in the spontaneously hypertensive rat

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 5, 2007, Pages

  MacDonnell, Scott M ^a   Kubo, Hajime ^a   Harris, David M ^c   Chen, Xiongwen ^a   Berretta, Remus ^a   Barbe, Mary F ^b   Kolwicz, Stephen ^b   Reger, Patricia O ^b   Eckhart, Andrea ^c   Renna, Brian F ^b   Koch, Walter J ^c   Houser, Steven R ^a,b   Libonati, Joseph R ^a,b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Calcium calmodulin kinase II; Hypertrophy; Myocardium; Phosphatase; Protein kinase A

Indexed keywords

BETA ADRENERGIC RECEPTOR; CALCINEURIN INHIBITOR; CALCIUM ION; CYCLOSPORIN A; ISOPRENALINE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; BODY WEIGHT; CONTROLLED STUDY; FEMALE; HEART MUSCLE CONTRACTILITY; HEART WEIGHT; HYPERTENSION; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOPLASMIC RETICULUM; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; WISTAR KYOTO RAT;

ANIMALS; CALCINEURIN; CALCIUM; CALCIUM SIGNALING; CELLS, CULTURED; FEMALE; HYPERTENSION; MYOCYTES, CARDIAC; PHOSPHORYLATION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, ADRENERGIC, BETA;

EID: 36148984929     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00687.2007     Document Type: Article

References (38)

1. Bailey BA, Houser SR. Calcium transients in feline left ventricular myocytes with hypertrophy induced by slow progressive pressure overload. J Mol Cell Cardiol 24: 365-373, 1992.
2. 2+-release channels in rat heart. Biochem J 352: 61-70, 2000.
3. Boluyt MO, O'Neill L, Meredith AL, Bing OH, Brooks WW, Conrad CH, Crow MT, Lakatta EG. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extracellular matrix components. Circ Res 75: 23-32, 1994.
4. Calderone A, Takahashi N, Izzo NJ Jr, Thaik CM, Colucci WS. Pressure- and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs. Circulation 92: 2385-2390, 1995.
5. Choi DJ, Koch WJ, Hunter JJ, Rockman HA. Mechanism of beta-adrenergic receptor desensitization in cardiac hypertrophy is increased beta-adrenergic receptor kinase. J Biol Chem 272: 17223-17229, 1997.
6. 2+ handling in a calcineurin transgenic model of heart failure. Cardiovasc Res 54: 105-116, 2002.
7. Doggrell SA, Brown L. Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res 39: 89-105, 1998.
8. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 44: 398-404, 2004.
9. Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the heart: a new therapeutic target? Circulation 109: 1580-1589, 2004.
10. Frohlich ED. Hemodynamic factors in the pathogenesis and maintenance of hypertension. Fed Proc 41: 2400-2408, 1982.
11. Griffiths EJ, Halestrap AP. Protection by cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts. J Mol Cell Cardiol 25: 1461-1469, 1993.
12. Jablonskis LT, Howe PR. Elevated plasma adrenaline in spontaneously hypertensive rats. Blood Press 3: 106-111, 1994.
13. 2+ exchange in phenylephrine-treated hypertrophic cardiomyocytes. J Biol Chem 280: 5764-5772, 2005.
14. Kolwicz SC, Kubo H, MacDonnell SM, Houser SR, Libonati JR. Effects of forskolin on inotropic performance and phospholamban phosphorylation in exercise-trained hypertensive myocardium. J Appl Physiol 102: 628-633, 2007.
15. Libonati JR, Gaughan JP, Hefner CA, Gow A, Paolone AM, Houser SR. Reduced ischemia and reperfusion injury following exercise training. Med Sci Sports Exerc 29: 509-516, 1997.
16. Libonati JR, Kendrick ZV, Houser SR. Sprint training improves postischemic, left ventricular diastolic performance. J Appl Physiol 99: 2121-2127, 2005.
17. Lim HW, De Windt LJ, Steinberg L, Taigen T, Witt SA, Kimball TR, Molkentin JD. Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy. Circulation 101: 2431-2437, 2000.
18. Limas C, Limas CJ. Reduced number of beta-adrenergic receptors in the myocardium of spontaneously hypertensive rats. Biochem Biophys Res Commun 83: 710-714, 1978.
19. MacDonnell SM, Kubo H, Crabbe DL, Renna BF, Reger PO, Mohara J, Smithwick LA, Koch WJ, Houser SR, Libonati JR. Improved myocardial β-adrenergic responsiveness and signaling with exercise training in hypertension. Circulation 111: 3420-3428, 2005.
20. Molkentin JD. Calcineurin and beyond: cardiac hypertrophic signaling. Circ Res 87: 731-738, 2000.
21. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93: 215-228, 1998.
22. Munch G, Bolck B, Karczewski P, Schwinger RH. Evidence for calcineurin-mediated regulation of SERCA 2a activity in human myocardium. J Mol Cell Cardiol 34: 321-334, 2002.
23. Nathan M, Friehs I, Choi YH, Cowan DB, Cao-Danh H, McGowan FX, del Nido PJ. Cyclosporin A but not FK-506 protects against dopamine-induced apoptosis in the stunned heart. Ann Thorac Surg 79: 1620-1626, 2005.
24. 2+ sparklet activity in arterial smooth muscle. J Gen Physiol 127: 611-622, 2006.
25. Petrashevskaya NN, Bodi I, Rubio M, Molkentin JD, Schwartz A. Cardiac function and electrical remodeling of the calcineurin-overexpressed transgenic mouse. Cardiovasc Res 54: 117-132, 2002.
26. Pfeffer J, Pfeffer M, Fletcher P, Braunwald E. Alterations of cardiac performance in rats with established spontaneous hypertension. Am J Cardiol 44: 994-998, 1979.
27. Sander M, Lyson T, Thomas GD, Victor RG. Sympathetic neural mechanisms of cyclosporine-induced hypertension. Am J Hypertens 9: 121S-138S, 1996.
28. Santana LF, Chase EG, Votaw VS, Nelson MT, Greven R. Functional coupling of calcineurin and protein kinase A in mouse ventricular myocytes. J Physiol 544: 57-69, 2002.
29. Saragoca M, Tarazi RC. Impaired cardiac contractile response to isoproterenol in the spontaneously hypertensive rat. Hypertension 3: 380-385, 1981.
30. Silver LH, Hemwall EL, Marino TA, Houser SR. Isolation and morphology of calcium-tolerant feline ventricular myocytes. Am J Physiol Heart Circ Physiol 245: H891-H896, 1983.
31. Sulakhe PV, Vo XT, Morris TE, Pato MD, Khandelwal RL. Protein phosphorylation in rat cardiac microsomes: effects of inhibitors of protein kinase A and of phosphatases. Mol Cell Biochem 175: 109-115, 1997.
32. Taigen T, De Windt LJ, Lim HW, Molkentin JD. Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. Proc Natl Acad Sci USA 97: 1196-1201, 2000.
33. 2+ signalling and gene expression. J Physiol 554: 309-320, 2004.
34. Wilkins BJ, Molkentin JD. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun 322: 1178-1191, 2004.
35. Zhang W. Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy. Cardiovasc Res 53: 294-303, 2002.
36. Zhou X, Frohlich ED. Analogy of cardiac and renal complications in essential hypertension and aged SHR or L-NAME/SHR. Med Chem 3: 61-65, 2007.
37. Zou Y, Hiroi Y, Uozumi H, Takimoto E, Toko H, Zhu W, Kudoh S, Mizukami M, Shimoyama M, Shibasaki F, Nagai R, Yazaki Y, Komuro I. Calcineurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy. Circulation 104: 97-101, 2001.
38. Zou Y, Yao A, Zhu W, Kudoh S, Hiroi Y, Shimoyama M, Uozumi H, Kohmoto O, Takahashi T, Shibasaki F, Nagai R, Yazaki Y, Komuro I. Isoproterenol activates extracellular signal-regulated protein kinases in cardiomyocytes through calcineurin. Circulation 104: 102-108, 2001.